Dieter Hamprecht

发表

1,2,4-Triazol-3-yl-thiopropyl-tetrahydrobenzazepines: A Series of Potent and Selective Dopamine D3 Receptor Antagonists

J. Hagan, A. Schwarz, A. Capelli, 2007 .

Isoindolone derivatives, a new class of 5-HT2C antagonists: synthesis and biological evaluation.

G. Tedesco, M. Wood, D. Donati, 2007, Bioorganic & medicinal chemistry letters.

[3-azabicyclo[3.1.0]hex-1-yl]phenyl-benzenesulfonamides as selective dopamine D3 antagonists.

A. Prandi, C. Heidbreder, D. Donati, 2010, Bioorganic & medicinal chemistry letters.

BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy

D. Drucker, I. Uphues, H. Neubauer, 2022, Molecular metabolism.

Diaryl substituted pyrrolidinones and pyrrolones as 5-HT2C inhibitors: synthesis and biological evaluation.

G. Tedesco, G. Riley, M. Wood, 2006, Bioorganic & medicinal chemistry letters.

An activity‐based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti‐fibrotic therapeutic strategies

H. Schilter, W. Jarolimek, L. Perryman, 2021, Clinical and Translational Medicine.

1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.

A. Capelli, G. Tedesco, F. Blaney, 2010, Journal of medicinal chemistry.

5-HT2C antagonists based on fused heterotricyclic templates: design, synthesis and biological evaluation.

G. Tedesco, M. Wood, D. Donati, 2007, Bioorganic & medicinal chemistry letters.

14th International Isotope Society (UK group) symposium

John R. Jones, C. A. Austin, J. Passchier, 2005 .